Insulin glulisine

Details

Files
Generic Name:
Insulin glulisine
Project Status:
Complete
Therapeutic Area:
Diabetes, Mellitus (Type 1 & 2)
Manufacturer:
Sanofi-Aventis Canada Inc.
Brand Name:
Apidra
Project Line:
Reimbursement Review
Project Number:
SR0144-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes, Mellitus (Type 1 & 2)
Recommendation Type:
List in a similar manner to other drugs in class
Final Recommendation: